Immunoinformatics-based design and evaluation of a multi-epitope vaccine against Vibrio fluvialis

1. Brumfield, K. D. et al. Environmental parameters associated with incidence and transmission of pathogenic Vibrio spp. Environ. Microbiol. 23(12), 7314–7340 (2021).

   Google Scholar 

2. Lee, J. V., Shread, P., Furniss, A. L. & Bryant, T. N. Taxonomy and description of Vibrio fluvialis sp. Nov. (synonym group F vibrios, group EF6). J. Appl. Bacteriol. 50(1), 73–94 (1981).

   Google Scholar 

3. Abioye, O. E., Osunla, A. C. & Okoh, A. I. Molecular detection and distribution of six medically important Vibrio spp. in selected freshwater and brackish water resources in Eastern Cape Province, South Africa. Front Microbiol. 12, 617703 (2021).

   Google Scholar 

4. Zhou, Y. et al. Virulence, antibiotic resistance phenotypes and molecular characterisation of Vibrio furnissii isolates from patients with diarrhoea. BMC Infect Dis. 24(1), 412 (2024).

   Google Scholar 

5. Albert, V. et al. Comprehending the risk of foodborne and waterborne disease outbreaks: Current situation and control measures with Special reference to the Indian Scenario. Heliyon 10(16), e36344 (2024).

   Google Scholar 

6. Chowdhury, G. et al. An outbreak of foodborne gastroenteritis caused by dual pathogens, Salmonella enterica serovar Weltevreden and Vibrio fluvialis in Kolkata, India. Foodborne Pathog. Dis. 10(10), 940–906 (2013).

   Google Scholar 

7. Sodders, N., Stockdale, K., Baker, K., Ghanem, A., Vieth, B. & Harder, T. Notes from the field: Vibriosis cases associated with flood waters during and after hurricane Ian—Florida, September–October 2022. MMWR Morb Mortal Wkly Rep. 72(18) (2023).

8. Ovuru, K. F., Izah, S. C., Ogidi, O. I., Imarhiagbe, O. & Ogwu, M. C. Slaughterhouse facilities in developing nations: Sanitation and hygiene practices, microbial contaminants and sustainable management system. Food Sci. Biotechnol. 33(3), 519–537 (2024).

   Google Scholar 

9. Mohebi, S., Saboorian, R. & Shams, S. The first report of Vibrio fluvialis isolated from a clinical sample in Iran. Iran J. Microbiol. 14(5), 677 (2022).

   Google Scholar 

10. Bej, S. et al. Wastewater-associated infections: A public health concern. Water Air Soil Pollut. 234(7), 444 (2023).

    Google Scholar 

11. Nalin, D. R. The history of intravenous and oral rehydration and maintenance therapy of cholera and non-cholera dehydrating diarrheas: A deconstruction of translational medicine: From bench to bedside?. Trop. Med. Infect. Dis. 7(3), 50 (2022).

    Google Scholar 

12. Koutsoumanis, K. et al. Public health aspects of Vibrio spp. related to the consumption of seafood in the EU. Efsa J. 22(7), e8896 (2024).

    Google Scholar 

13. Jayakumar, J. M. et al. Climate change and Vibrio vulnificus dynamics: A blueprint for infectious diseases. PLoS Pathog. 20(12), e1012767 (2024).

    Google Scholar 

14. Xiao, H. et al. Evaluation of the multivalent immune protective effects of the Vibrio fluvialis outer membrane protein VF17320, and its DNA and IgY antibody vaccines in fish. Front Vet Sci. 12, 1586258 (2025).

    Google Scholar 

15. Lim, S. M. & Webb, S. A. Nosocomial bacterial infections in Intensive Care Units. I: Organisms and mechanisms of antibiotic resistance. Anaesthesia 60(9), 887–902 (2005).

    Google Scholar 

16. Chiș, A. A. et al. Microbial resistance to antibiotics and effective antibiotherapy. Biomedicines 10(5), 1121 (2022).

    Google Scholar 

17. Miller, W. R. & Arias, C. A. ESKAPE pathogens: Antimicrobial resistance, epidemiology, clinical impact and therapeutics. Nat. Rev. Microbiol. 22(10), 598–616 (2024).

    Google Scholar 

18. Sarma, D., Chandra, S. & Mallik, S. K. Aquaculture and Conservation of Inland Coldwater Fishes (Springer, New York, 2024).

    Google Scholar 

19. Mishra, A., Kim, H. S., Kumar, R. & Srivastava, V. Advances in vibrio-related infection management: an integrated technology approach for aquaculture and human health. Crit. Rev. Biotechnol. 44(8), 1610–1637 (2024).

    Google Scholar 

20. Solana, J. C., Moreno, J., Iborra, S., Soto, M. & Requena, J. M. Live attenuated vaccines, a favorable strategy to provide long-term immunity against protozoan diseases. Trends Parasitol. 38(4), 316–334 (2022).

    Google Scholar 

21. Prakash, S. et al. Cross-protection induced by highly conserved human B, CD4(+), and CD8(+) T-cell epitopes-based vaccine against severe infection, disease, and death caused by multiple SARS-CoV-2 variants of concern. Front Immunol. 15, 1328905 (2024).

    Google Scholar 

22. Bhattacharjee, M., Banerjee, M. & Mukherjee, A. Advanced in silico design of an optimized multi-epitope peptide vaccine employing immunoinformatics and reverse vaccinology strategies on the model of Listeria monocytogenes. J. Proteins Proteom. 16(2), 1–24 (2025).

    Google Scholar 

23. Yan, Q. Pharmacogenomics in Drug Discovery and Development (Springer, New York, 2008).

    Google Scholar 

24. Singh, D. B. Computer-Aided Drug Design (Springer, New York, 2020).

    Google Scholar 

25. Xiao, H. et al. Evaluation of the multivalent immunoprotective effects of protein, DNA, and IgY vaccines against Vibrio fluvialis outer membrane protein VF14355 in Carassius auratus. Int. J. Mol. Sci. 26(7), 3379 (2025).

    Google Scholar 

26. Oladipo, E. K. et al. Bioinformatics analysis of structural protein to approach a vaccine candidate against Vibrio cholerae infection. Immunogenetics 75(2), 99–114 (2023).

    Google Scholar 

27. Li, C. et al. Identification of a novel vaccine candidate by immunogenic screening of Vibrio parahaemolyticus outer membrane proteins. Vaccine. 32(46), 6115–6121 (2014).

    Google Scholar 

28. Basmenj, E. R. et al. Computational epitope-based vaccine design with bioinformatics approach: A review. Heliyon. 11(1), e41714 (2025).

    Google Scholar 

29. Bieniossek, C. et al. The molecular architecture of the metalloprotease FtsH. Proc. Natl. Acad. Sci. U. S. A. 103(9), 3066–3071 (2006).

    Google Scholar 

30. Weaver, A. I. et al. Lytic transglycosylases RlpA and MltC assist in Vibrio cholerae daughter cell separation. Mol Microbiol. 112(4), 1100–1115 (2019).

    Google Scholar 

31. Ahmad, S. et al. The UniProt website API: Facilitating programmatic access to protein knowledge. Nucleic Acids Res. (2025).

32. Doytchinova, I. A. & Flower, D. R. VaxiJen: A server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinform. 8(1), 4 (2007).

    Google Scholar 

33. Dimitrov, I., Bangov, I., Flower, D. R. & Doytchinova, I. AllerTOP v. 2—a server for in silico prediction of allergens. J. Mol. Model. 20(6), 2278 (2014).

    Google Scholar 

34. Teufel, F. et al. SignalP 6.0 predicts all five types of signal peptides using protein language models. Nat. Biotechnol. 40(7), 1023–1025 (2022).

    Google Scholar 

35. Roohparvar Basmenj, E. et al. A novel approach to design a multiepitope peptide as a vaccine candidate for Bordetella pertussis. J. Biomol. Struct. Dyn. 42(24), 13738–13750 (2024).

    Google Scholar 

36. Acha Alarcon, L. et al. Identification of Streptococcus pneumoniae-specific proteins by surface-shaving proteomics. J. Proteome Res. 24, 6154–6173 (2025).

    Google Scholar 

37. Prado, L. C. D. S. et al. New putative therapeutic targets against Serratia marcescens using reverse vaccinology and subtractive genomics. J. Biomol. Struct. Dyn. 40(20), 10106–10121 (2022).

    Google Scholar 

38. Yan, Z. et al. Next-generation IEDB tools: A platform for epitope prediction and analysis. Nucleic Acids Res. 52(W1), W526–W532 (2024).

    Google Scholar 

39. Dimitrov, I., Zaharieva, N. & Doytchinova, I. Bacterial immunogenicity prediction by machine learning methods. Vaccines (Basel). 8(4), 709 (2020).

    Google Scholar 

40. Bui, H. H., Sidney, J., Li, W., Fusseder, N. & Sette, A. Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines. BMC Bioinform. 8, 361 (2007).

    Google Scholar 

41. Roohparvar Basmenj, E., Omidvar, B., Kiumarsy, A., Izadkhah, H. & Ghiabi, S. Design of a multi-epitope-based peptide vaccine against the SARS-CoV-2 Omicron variant using bioinformatics approach. J. Biomol. Struct. Dyn. 42(15), 7945–7956 (2024).

    Google Scholar 

42. Bui, H. H. et al. Predicting population coverage of T-cell epitope-based diagnostics and vaccines. BMC Bioinform. 7, 153 (2006).

    Google Scholar 

43. Mishra, S. K. et al. Integrated immunoinformatics and reverse vaccinology assisted novel multi-epitope vaccine against Coxsackievirus A10 investigating its whole genome encoded polyprotein. J. Mol. Liq. 433, 127883 (2025).

    Google Scholar 

44. Kumar Mishra, S. et al. An integrated mutation-based immunoinformatic approach incorporating variability in epitopes: A study based on HIV subtype C. Front Immunol. 16, 1540253 (2025).

    Google Scholar 

45. Zhao, T. et al. Vaccine adjuvants: Mechanisms and platforms. Signal Transduct. Target. Ther. 8(1), 283 (2023).

    Google Scholar 

46. Bramwell, V. W., Somavarapu, S., Outschoorn, I. & Alpar, H. O. Adjuvant action of melittin following intranasal immunisation with tetanus and diphtheria toxoids. J. Drug Target. 11(8–10), 525–530 (2003).

    Google Scholar 

47. Alqarni, A. M., Ferro, V. A., Parkinson, J. A., Dufton, M. J. & Watson, D. G. Effect of melittin on metabolomic profile and cytokine production in PMA-differentiated THP-1 cells. Vaccines (Basel) 6(4), 72 (2018).

    Google Scholar 

48. Sanches, R. C. O. et al. Immunoinformatics design of multi-epitope peptide-based vaccine against Schistosoma mansoni using transmembrane proteins as a target. Front Immunol. 12, 621706 (2021).

    Google Scholar 

49. Alsowayeh, N., Albutti, A. & Al-Shouli, S. T. Reverse vaccinology and immunoinformatic assisted designing of a multi-epitopes based vaccine against nosocomial Burkholderia cepacia. Front Microbiol. 13, 929400 (2022).

    Google Scholar 

50. Naveed, M. et al. Development of a broad-spectrum multiepitope vaccine against dabie bandavirus through immunoinformatic approaches. Int Immunopharmacol. 166, 115492 (2025).

    Google Scholar 

51. Walker, J. M. The Proteomics Protocols Handbook (Springer, New York, 2005).

    Google Scholar 

52. Hanif, N. et al. In silico characterization of hypothetical protein AZJ53_10480 in Streptococcus pneumoniae. BioScientific Rev. 6(4), 1–12 (2024).

    Google Scholar 

53. Hon, J. et al. SoluProt: Prediction of soluble protein expression in Escherichia coli. Bioinformatics 37(1), 23–28 (2021).

    Google Scholar 

54. Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630(8016), 493–500 (2024).

    Google Scholar 

55. Seok, C. et al. Accurate protein structure prediction: What comes next. Biodesign 9(3), 47–50 (2021).

    Google Scholar 

56. Laskowski, R. A., MacArthur, M. W., Moss, D. S. & Thornton, J. M. PROCHECK: A program to check the stereochemical quality of protein structures. Appl. Crystallogr. 26(2), 283–291 (1993).

    Google Scholar 

57. Hanif, N. et al. Computational drug design targeting MYH7 for hypertrophic cardiomyopathy integrating molecular docking, Density Functional Theory, and Molecular Dynamics Simulations. J. Appl. Biol. Sci. 19(3), 179–192 (2025).

    Google Scholar 

58. Wiederstein, M. & Sippl, M. J. ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res. 35(suppl_2), W407–W410 (2007).

    Google Scholar 

59. Ponomarenko, J. et al. ElliPro: A new structure-based tool for the prediction of antibody epitopes. BMC Bioinform. 9, 514 (2008).

    Google Scholar 

60. Mishra, S. K. et al. Integrated immuno and bioinformatics assisted novel epitope vaccine against HIV infection: A study based on complete genome. Virol. J. 22(1), 228 (2025).

    Google Scholar 

61. Yan, Y., Tao, H., He, J. & Huang, S.-Y. The HDOCK server for integrated protein–protein docking. Nat. Protocols. 15(5), 1829–1852 (2020).

    Google Scholar 

62. Oliveira-Nascimento, L., Massari, P. & Wetzler, L. M. The role of TLR2 in infection and immunity. Front. Immunol. 3, 79 (2012).

    Google Scholar 

63. Singh, S. et al. In-silico development of a novel TLR2-mediating multi-epitope vaccine against Mycobacterium tuberculosis. In Silico Pharmacol. 13(1), 34 (2025).

    Google Scholar 

64. Kozakov, D. et al. The ClusPro web server for protein–protein docking. Nat. Protocols 12(2), 255–278 (2017).

    Google Scholar 

65. Laskowski, R. A. PDBsum 1: A standalone program for generating PDBsum analyses. Protein Sci. 31(12), e4473 (2022).

    Google Scholar 

66. Sadia, H. et al. Natural AI-based drug designing by modification of ascorbic acid and curcumin to combat buprofezin toxicity by using molecular dynamics study. Sci. Rep. 14(1), 28445 (2024).

    Google Scholar 

67. Naveed, M. et al. Computational drug design for neurosyphilis disease by targeting Phosphoglycerate Kinase in Treponema pallidum with enhanced binding affinity and reduced toxicity. Sci. Rep. 15, 1–22 (2025).

    Google Scholar 

68. Naveed, M. et al. In-silico and computational active site-driven design and characterization of beta-NGF-Ab fusion protein as a novel and targeted Alzheimer’s disease therapy. J. Comput. Biophys. Chem. 1(16), 16 (2025).

    Google Scholar 

69. Naveed, M. et al. Combining network pharmacology and computational approaches for screening of apiaceae-derived phytochemicals as inhibitors of DNA polymerase III in Streptococcus pyogenes causing streptococcal toxic shock syndrome. Chinese J. Anal. Chem. 53, 100632 (2025).

70. Naveed, M. et al. Rational computational design and development of an immunogenic multiepitope vaccine incorporating transmembrane proteins of Fusobacterium necrophorum. Sci. Rep. 15(1), 15587 (2025).

    Google Scholar 

71. Laubenbacher, R. et al. Toward mechanistic medical digital twins: some use cases in immunology. Front. Digit. Health 6, 1349595 (2024).

    Google Scholar 

72. Madeira, F. et al. The EMBL-EBI job dispatcher sequence analysis tools framework in 2024. Nucleic Acids Res. 52(W1), W521–W525 (2024).

    Google Scholar 

73. Yin, Z. et al. Design of multi-epitope vaccine candidate against Brucella type IV secretion system (T4SS). PLoS ONE 18(8), e0286358 (2023).

    Google Scholar 

74. Naveed, M. et al. Designing IL-24–P18 fusion protein through computational engineering for targeted breast cancer therapy. J. Comput. Biophys. Chem. 25(1), 109–123 (2026).

    Google Scholar 

75. Takezawa, T. et al. Vibrio fluvialis bacteremia in an immunocompetent patient with acute cholangitis. Internal Med. 63(22), 3101–3104 (2024).

    Google Scholar 

76. Wang, Y., Luo, J., Zhao, Y., Zhang, J., Guan, X. & Sun, L. Haemolysins are essential to the pathogenicity of deep-sea Vibrio fluvialis. iScience 27(5),109558 (2024).

77. Zheng, H. et al. Population genomics of the food-borne pathogen Vibrio fluvialis reveals lineage associated pathogenicity-related genetic elements. Microb Genom. 8(2), 000769 (2022).

    Google Scholar 

78. Ramalingam, P. S. & Arumugam, S. Reverse vaccinology and immunoinformatics approaches to design multi-epitope based vaccine against oncogenic KRAS. Med Oncol. 40(10), 283 (2023).

    Google Scholar 

79. Qiu, J. et al. Integrated in-silico design and in vivo validation of multi-epitope vaccines for norovirus. Virol J. 22(1), 166 (2025).

    Google Scholar 

80. Moradkasani, S. et al. Development of a multi-epitope vaccine from outer membrane proteins and identification of novel drug targets against Francisella tularensis: An in silico approach. Front Immunol. 16, 1479862 (2025).

    Google Scholar 

81. Guo, W. et al. In silico design of a multi-epitope vaccine against Mycobacterium avium subspecies paratuberculosis. Front Immunol. 16, 1505313 (2025).

    Google Scholar 

82. Roy, A. et al. Integrating pan-genome and reverse vaccinology to design multi-epitope vaccine against Herpes simplex virus type-1. 3 Biotech. 14(7), 176 (2024).

    Google Scholar 

83. Biswas, R. et al. Designing multi-epitope vaccine against human cytomegalovirus integrating pan-genome and reverse vaccinology pipelines. Biologicals 87, 101782 (2024).

    Google Scholar 

84. Koupaei, F. N. et al. Design of a multi-epitope vaccine candidate against Vibrio cholerae. Sci. Rep. 15(1), 11033 (2025).

    Google Scholar 

85. Tahir Ul Qamar, M. et al. Designing multi-epitope vaccine against Staphylococcus aureus by employing subtractive proteomics, reverse vaccinology and immuno-informatics approaches. Comput. Biol. Med. 132, 104389 (2021).

    Google Scholar 

86. Zhu, F. et al. Designing a multi-epitope vaccine against Pseudomonas aeruginosa via integrating reverse vaccinology with immunoinformatics approaches. Sci. Rep. 15(1), 10425 (2025).

    Google Scholar 

87. Naveed, M. et al. Integrating 16S rRNA identification for a promising epitope-based vaccine strategy against Bacillus licheniformis infections causing foodborne illness. Allergol. Immunopathol. 54(1), 105–122 (2026).

    Google Scholar 

88. Biswas, R. & Anbarasu, A. Identification of novel zinc-binding inhibitors against key microbial metallohydrolase DapE in Klebsiella pneumoniae: An integrated ligand-based virtual screening, molecular docking, molecular dynamics, and MM/PBSA approach. Integr. Biol. 17, zyaf018 (2025).

    Google Scholar 

Download references